Normal view MARC view ISBD view

Purification and characterization of 2-halocarboxylic acid dehalogenase II from Pseudomonas spec. CBS 3. [electronic resource]

By:

Mörsberger, F M

Contributor(s):

Producer: 19920228Description: 915-22 p. digitalISSN:

0177-3593

Subject(s):

Online resources:

Available from publisher's website

In: Biological chemistry Hoppe-Seyler vol. 372

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

1 Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance.
by Retèl, Valesca P
2 Experts reflecting on the duty to recontact patients and research participants; why professionals should take the lead in developing guidelines.
by Mitchell, Colin
3 Molecular profiling is rather likely to be cost effective.
by Retèl, Valesca P
4 Evidence Underlying Policy Proposals for Sustainable Anticancer Drug Prices: A Systematic Review.
by Franzen, Nora
5 Early phase Technology Assessment of nanotechnology in oncology.
by Retèl, Valesca P
6 Review on early technology assessments of nanotechnologies in oncology.
by Retèl, Valesca P
7 A systematic and critical review of the evolving methods and applications of value of information in academia and practice.
by Steuten, Lotte
8 The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review.
by van Delft, Frederik
9 Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy.
by Miquel-Cases, Anna
10 Value of research and value of development in early assessments of new medical technologies.
by Retèl, Valesca P
11 Decisions on Further Research for Predictive Biomarkers of High-Dose Alkylating Chemotherapy in Triple-Negative Breast Cancer: A Value of Information Analysis.
by Miquel-Cases, Anna
12 Knowledge of genomic testing among early-stage breast cancer patients.
by Richman, Alice R
13 Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer.
by Retèl, Valesca P
14 Scenario drafting to anticipate future developments in technology assessment.
by Retèl, Valesca P
15 The cost-effectiveness of TheraBite® as treatment for acute myogenic temporomandibular disorder.
by Heres Diddens, Andreas
16 Impact of organ-on-a-chip technology on pharmaceutical R&D costs.
by Franzen, Nora
17 Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients.
by Miquel-Cases, Anna
18 Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study.
by Retèl, Valesca P
19 A cost-effectiveness analysis of using TheraBite in a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.
by Retèl, Valesca P
20 Design of a randomized controlled trial of Internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors.
by Atema, Vera